Anand Patel1, Jacquelyn Dunmore-Griffith1, Stephen Lutz2, Peter A S Johnstone3. 1. Department of Radiation Oncology, Howard University Hospital, Washington, DC 20001, United States. 2. Department of Radiation Oncology, Blanchard Valley Health System, Findlay, OH 45840, United States. 3. Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
Abstract
AIM: We sought to survey a large, multi-center patient sample to better characterize/quantify RT utilization at the end of life. BACKGROUND: Few objective data exist for radiation therapy (RT) delivery at end of life (EOL). MATERIALS AND METHODS: Data were retrieved for all patients receiving RT in calendar year 2010 in the Department of Radiation Oncology at Indiana University (IU) and Howard University (HU) hospitals. Specific attention was made of the group of patients receiving RT in the last 30 days of life. RESULTS: A total of 852 patients received all or part of their RT during 2010 (HU: 139, IU: 713). At time of analysis in early 2012, 179 patients had died (21%). Fifty-four patients (6.3% of total; 30% of expired patients) died within 30 days of receiving their last treatment. Twenty patients (2.3% of total; 11.2% of expired patients) received RT within their last week of life. For both sites, the median time until death from completion of therapy was 12.5 days (range 2-30 days). CONCLUSIONS: Radiation in the last month of life is likely to provide minimal palliation or survival benefit. This, coupled with the financial implications, time investment, and physical costs, suggests that physicians and patients should more strongly consider hospice, and minimize duration of palliative RT courses as far as possible. As with chemotherapy, RT utilization at EOL should be considered for collection as an overuse metric.
AIM: We sought to survey a large, multi-center patient sample to better characterize/quantify RT utilization at the end of life. BACKGROUND: Few objective data exist for radiation therapy (RT) delivery at end of life (EOL). MATERIALS AND METHODS: Data were retrieved for all patients receiving RT in calendar year 2010 in the Department of Radiation Oncology at Indiana University (IU) and Howard University (HU) hospitals. Specific attention was made of the group of patients receiving RT in the last 30 days of life. RESULTS: A total of 852 patients received all or part of their RT during 2010 (HU: 139, IU: 713). At time of analysis in early 2012, 179 patients had died (21%). Fifty-four patients (6.3% of total; 30% of expired patients) died within 30 days of receiving their last treatment. Twenty patients (2.3% of total; 11.2% of expired patients) received RT within their last week of life. For both sites, the median time until death from completion of therapy was 12.5 days (range 2-30 days). CONCLUSIONS: Radiation in the last month of life is likely to provide minimal palliation or survival benefit. This, coupled with the financial implications, time investment, and physical costs, suggests that physicians and patients should more strongly consider hospice, and minimize duration of palliative RT courses as far as possible. As with chemotherapy, RT utilization at EOL should be considered for collection as an overuse metric.
Entities:
Keywords:
Health services research; Palliative care; Radiotherapy
Authors: Michael N Neuss; Christopher E Desch; Kristen K McNiff; Peter D Eisenberg; Dean H Gesme; Joseph O Jacobson; Mohammad Jahanzeb; Jennifer J Padberg; John M Rainey; Jeff J Guo; Joseph V Simone Journal: J Clin Oncol Date: 2005-08-08 Impact factor: 44.544
Authors: Federico L Ampil; Gloria Caldito; Glenn Mills; Jay Marion; Andrei Balandin; John Ponugupati Journal: Am J Hosp Palliat Care Date: 2012-06-27 Impact factor: 2.500
Authors: Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch Journal: N Engl J Med Date: 2010-08-19 Impact factor: 91.245
Authors: Nirav S Kapadia; Rizvan Mamet; Carrie Zornosa; Joyce C Niland; Thomas A D'Amico; James A Hayman Journal: Cancer Date: 2012-01-17 Impact factor: 6.860
Authors: Alysa Fairchild; Elizabeth Barnes; Sunita Ghosh; Edgar Ben-Josef; Daniel Roos; William Hartsell; Tanya Holt; Jackson Wu; Nora Janjan; Edward Chow Journal: Int J Radiat Oncol Biol Phys Date: 2009-05-21 Impact factor: 7.038
Authors: Dirk Rades; Barbara Segedin; Steven E Schild; Darejan Lomidze; Theo Veninga; Jon Cacicedo Journal: Radiat Oncol Date: 2022-08-17 Impact factor: 4.309
Authors: Haley K Perlow; Vincent Cassidy; Benjamin Farnia; Deukwoo Kwon; Adam W Awerbuch; Stephanie Ciraula; Scott Alford; Jacob Griggs; Joseph A Quintana; Raphael Yechieli; Stuart E Samuels Journal: Adv Radiat Oncol Date: 2018-09-14